Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01358695 · ClinicalTrials.gov registry record · Phase 2
Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet
A Phase 2 study, sponsored by Anterios.
- Completed
- Registry status
- Phase 2
- Development phase
- 111
- Enrollment target
NCT01358695 is a Phase 2 study that has completed, run by Anterios. The registered enrollment target is 111 participants.
The verdict
NCT01358695, a Phase 2 study, has completed, sponsored by Anterios.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 111 participants
- Enrollment target
Study Summary
The purpose of this study is to provide evidence of the safety, tolerance, and efficacy of ANT-1207 in the treatment of Crow's Feet.
Interventions
- BIOLOGICAL Botulinum Toxin Type A
- BIOLOGICAL ANT-1207
- BIOLOGICAL Botulinum Toxin, Type A
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01358695
The ClinicalTrials.gov registry entry for NCT01358695 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Anterios, which has 5 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Botulinum Toxin Type A is the first listed.
NCT01358695 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01358695 about?
NCT01358695 is a clinical study titled "Clinical Trial To Evaluate ANT-1207 In Subjects With Crow's Feet". The purpose of this study is to provide evidence of the safety, tolerance, and efficacy of ANT-1207 in the treatment of Crow's Feet.
What is the current status of trial NCT01358695?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 111 participants. The study started on 2011-05. Estimated completion is 2012-05.
What interventions are being tested in trial NCT01358695?
The interventions under investigation include: Botulinum Toxin Type A (BIOLOGICAL), ANT-1207 (BIOLOGICAL), Botulinum Toxin, Type A (BIOLOGICAL).
Who is sponsoring clinical trial NCT01358695?
This trial is sponsored by Anterios, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.